Autologous Stem Cell Transplantation for Patients With Recurrent Nasopharyngeal Carcinoma
Status:
Terminated
Trial end date:
2017-05-09
Target enrollment:
Participant gender:
Summary
This is a pilot study to evaluate the response rates for patients undergoing high dose
conditioning chemotherapy using Etoposide, Carboplatin and Ifosfamide followed by autologous
stem cell transplantation for the treatment of recurrent Nasopharyngeal Cancer (NPC) in
children, adolescents, and young adults.